Based on the fragmented search results (which appear to be archival snippets rather than a cohesive "LK.rar" document), I cannot produce a paper from a specific file named "LK.rar".
The combination of lowering glucose absorption (PGX) and enhancing insulin action (sitagliptin) produces a greater reduction in hyperglycemia compared to either agent alone. 4. Discussion & Conclusion
A dipeptidyl peptidase 4 (DPP4) inhibitor that increases glucagon-like peptide-1 (GLP-1) [17].
The increasing prevalence of Type 2 Diabetes (T2D) and the need for improved blood glucose control.
1. Introduction
PGX acts to slow carbohydrate absorption (increasing viscosity) [17].
Potential for a superior nutritional/pharmacological combination therapy for humans with T2D.